- Home
- STGW vs INVA Comparison
STGW vs INVA Comparison
Compare STGW & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STGW
- INVA
- Stock Information
- Founded
- STGW 1980
- INVA 1996
- Country
- STGW United States
- INVA United States
- Employees
- STGW N/A
- INVA N/A
- Industry
- STGW
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- STGW
- INVA Health Care
- Exchange
- STGW Nasdaq
- INVA Nasdaq
- Market Cap
- STGW 1.4B
- INVA 1.3B
- IPO Year
- STGW N/A
- INVA 2004
- Fundamental
- Price
- STGW $5.57
- INVA $19.43
- Analyst Decision
- STGW Buy
- INVA Strong Buy
- Analyst Count
- STGW 5
- INVA 4
- Target Price
- STGW $8.17
- INVA $40.25
- AVG Volume (30 Days)
- STGW 884.5K
- INVA 674.8K
- Earning Date
- STGW 11-06-2025
- INVA 11-05-2025
- Dividend Yield
- STGW N/A
- INVA N/A
- EPS Growth
- STGW N/A
- INVA N/A
- EPS
- STGW N/A
- INVA 0.53
- Revenue
- STGW $2,858,547,000.00
- INVA $370,229,000.00
- Revenue This Year
- STGW $4.81
- INVA $8.17
- Revenue Next Year
- STGW $8.73
- INVA $12.06
- P/E Ratio
- STGW N/A
- INVA $36.19
- Revenue Growth
- STGW 9.37
- INVA 12.02
- 52 Week Low
- STGW $4.03
- INVA $16.67
- 52 Week High
- STGW $8.18
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- STGW 52.82
- INVA 41.25
- Support Level
- STGW $5.33
- INVA $19.60
- Resistance Level
- STGW $5.74
- INVA $21.11
- Average True Range (ATR)
- STGW 0.18
- INVA 0.49
- MACD
- STGW -0.04
- INVA -0.11
- Stochastic Oscillator
- STGW 52.17
- INVA 15.92
About STGW Stagwell Inc.
Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.